The global Compound Pediatric Antipyretic Suppository market size is predicted to grow from US$ 16.5 million in 2025 to US$ 21.7 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

Compound pediatric antipyretic suppository is a non-oral antipyretic drug designed for children, usually used to relieve fever symptoms caused by colds, flu or other diseases. This preparation is administered rectally, can be quickly absorbed and work, and is particularly suitable for infants and children who cannot swallow tablets or liquid medicines.

United States market for Compound Pediatric Antipyretic Suppository is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Compound Pediatric Antipyretic Suppository is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Compound Pediatric Antipyretic Suppository is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Compound Pediatric Antipyretic Suppository players cover Jiangxi Jiuhua Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd., Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd., Heilongjiang Tianlong Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Compound Pediatric Antipyretic Suppository Industry Forecast” looks at past sales and reviews total world Compound Pediatric Antipyretic Suppository sales in 2024, providing a comprehensive analysis by region and market sector of projected Compound Pediatric Antipyretic Suppository sales for 2025 through 2031. With Compound Pediatric Antipyretic Suppository sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Compound Pediatric Antipyretic Suppository industry.

This Insight Report provides a comprehensive analysis of the global Compound Pediatric Antipyretic Suppository landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Compound Pediatric Antipyretic Suppository portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Compound Pediatric Antipyretic Suppository market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Compound Pediatric Antipyretic Suppository and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Compound Pediatric Antipyretic Suppository.

This report presents a comprehensive overview, market shares, and growth opportunities of Compound Pediatric Antipyretic Suppository market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    0.7g/Tablet
    1g/Tablet

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Jiangxi Jiuhua Pharmaceutical Co., Ltd.
    Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd.
    Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd.
    Heilongjiang Tianlong Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Compound Pediatric Antipyretic Suppository market?
What factors are driving Compound Pediatric Antipyretic Suppository market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Compound Pediatric Antipyretic Suppository market opportunities vary by end market size?
How does Compound Pediatric Antipyretic Suppository break out by Type, by Application?